Daming Zuo

24PUBLICATIONS
43CO-AUTHORS
Medical virologyProteomics and metabolomicsInnate immunityMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Apr 29, 2026
Macrophage-derived MBL restrains coronavirus-induced pulmonary inflammation by modulating metabolic regulator PKM2-mediated NLRP3 activation.

|Dec 02, 2025
Population-Based Multi-Omics and Cohort Study Identifying Predictive Biomarkers and Therapeutic Targets for Psoriatic Disease.

Tianxing Wu, Jialiang Luo, Haoyuan Qiu

|May 17, 2025
Hepatocyte-expressed HERC2 enhances type I interferon-mediated anti-HBV immune response by promoting K33 ubiquitination of TBK1.

Zhuojun Zheng, Sihang Cao, Yunzhi Liu

|Oct 23, 2024
Hepatocyte-Targeted Lipid Nanoparticle Delivery of HERC2 Plasmid Controls Drug-Induced Hepatotoxicity by Limiting β-Catenin-Regulated CYP2E1 Expression.

Yunzhi Liu, Qishan Xu, Yan Liu

|Mar 22, 2024
Fucoidan suppresses proliferation and epithelial-mesenchymal transition process via Wnt/β-catenin signalling in hemangioma.

Zhengyumeng Zhu, Jialiang Luo, Lei Li

|Feb 02, 2023
A hnRNPA2B1 agonist effectively inhibits HBV and SARS-CoV-2 omicron in vivo.

Daming Zuo, Yu Chen, Jian-Piao Cai

Pageof 4

Frequent Collaborators

4 joint publications

Jia Zhou

3 joint publications

Zhengliang Chen

3 joint publications

Xiang-Yang Wang

2 joint publications

Shuofeng Yuan